News
According to a study funded by Eli Lilly, the trial revealed that participants taking tirzepatide, the drug sold as ...
Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results